NCT04157166

Brief Summary

The purpose of the OSS study is to evaluate a procedure involving a single full body SPECT/CT (Single photon emission computed tomography coupled with a computerized tomography) 3D recording with a new semiconductor camera,his name is VERITON-CT ™ (Spectrum Dynamics Medical). This recording can be done in less than 25 minutes due to an original system of CZT (Cadmium-Zinc-Telluride) detectors allowing to increase the quality of the images and especially, to multiply by a factor 2 to 3 the detection sensitivity. This camera is also equipped with a scanner capable of obtaining a body-to-integer recording with a low level of irradiation (≤ 2 mSv)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 8, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

February 4, 2020

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2022

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2023

Completed
Last Updated

June 25, 2026

Status Verified

June 1, 2024

Enrollment Period

2.4 years

First QC Date

November 6, 2019

Last Update Submit

June 23, 2026

Conditions

Keywords

Bone scansolid state gama camera CZT-based detectorhybrid SPECT/CT imagingbone metastasis

Outcome Measures

Primary Outcomes (1)

  • concordance between the two procedures

    Concordance between the 2 procedures of the importance of scintigraphic abnormalities evoking a neoplastic process and which will be classified into 3 categories (these categories may correspond to different medical and therapeutic care) : 1) absence of any suspicious focus, 2) 1 or 2 metastases 3) more than 2 metastases

    half hour

Secondary Outcomes (1)

  • concordance between the two procedures 3D

    half hour

Study Arms (2)

group 1 in pair week

EXPERIMENTAL

In pair week, patients will be included in group1:a conventional recording with SPECT/CT will be realized in first time

Diagnostic Test: Group 1 to record a 25 minutes whole body 3D in camera VERITON-CT ™ after scintigraphy + SPECT/CT in camera d'Anger

group 2 in odd week

EXPERIMENTAL

In odd week, patients will be included in group2: a 25 minutes recording 3D in camera VERITON-CT ™ will be realized in first time

Diagnostic Test: Group 1 to record a 25 minutes whole body 3D in camera VERITON-CT ™ after scintigraphy + SPECT/CT in camera d'Anger

Interventions

The procedure of recording of 25 minutes in camera VERITON-CT ™ including the registration whole body 3D coupled to a scanner low dose (CT) will be added to conventional recording followed by complementary images SPECT/CT in the second time for the group 1 and in the first time for the group 2

Also known as: Group 2 to record a 25 minutes whole body 3D in camera VERITON-CT ™ before scintigraphy + SPECT/CT in camera d'Anger
group 1 in pair weekgroup 2 in odd week

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient having read and understood the information document and having signed the consent.
  • Patient referred for bone scintigraphy to detect possible metastatic or primary neoplastic lesions (known neoplastic antecedent), or for assessment and / or follow-up of known neoplastic bone lesions
  • Patient agreeing to perform the additional 25 minutes of recording with the VERITON-CT ™ camera.
  • Patient being affiliated to a social security scheme

You may not qualify if:

  • A woman who is pregnant or of childbearing age and without suitable contraceptive means
  • No signature of the informed consent form by the patient.
  • Unstable medical condition and / or inability to remain still in the supine position during the recordings
  • Person with a known allergy to one of the components of the radiotracer (TECHNESCAN HDP).
  • Person deprived of liberty by a judicial or administrative decision.
  • Major person subject to a legal protection measure (guardianship, curatorship, safeguard of justice).
  • Major person unable to express consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Service de Médecine Nucléaire - CHRU de Nancy-Brabois

Vandœuvre-lès-Nancy, 54511, France

Location

Veronique Roch

Vandœuvre-lès-Nancy, 54511, France

Location

MeSH Terms

Interventions

Single Photon Emission Computed Tomography Computed Tomography

Intervention Hierarchy (Ancestors)

Tomography, Emission-Computed, Single-PhotonTomography, Emission-ComputedImage Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomography, X-Ray ComputedMultimodal ImagingRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayRadionuclide ImagingTomographyDiagnostic Techniques, Radioisotope

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: a group in which the conventional recording followed by complementary images in planar or SPECT, will be realized in first intention and the procedure of recording of 25 minutes in camera VERITON-CT ™ including the registration whole body 3D coupled to a scanner low dose (CT), will be performed just before and, * another group in which these recordings will be made in the reverse order
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicipal Investigator

Study Record Dates

First Submitted

November 6, 2019

First Posted

November 8, 2019

Study Start

February 4, 2020

Primary Completion

July 4, 2022

Study Completion

March 2, 2023

Last Updated

June 25, 2026

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations